According to results of a retrospective, real-world cohort study, glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be beneficial when used as adjunct therapy in the management of Crohns disease (CD) for patients who also have a diagnosis of overweight or obesity
When used as a medication (such as Semaglutide ), it mimics the hormone to: Suppress appetite Slow gastric emptying Improve insulin sensitivity Reduce food intake This mechanism makes GLP-1 for obesity management highly effective
Managing a Bruise if it Happens If you do find a bruise, dont worry
doi: 10.4103/jpbs.jpbs_94_25
In Monroe, many insurance plans now cover Wegovy, acknowledging the clinical benefits of GLP-1
This can lead to faster recovery from strains, sprains, and other injuries that might otherwise sideline you for weeks